Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis

Published:2021-12 Issue: Volume:33 Page:62-67
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Shlofmitz Evan,Case Brian C.,Chen Yuefeng,Chezar-Azerrad Chava,Hashim Hayder,Garcia-Garcia Hector M.,Mintz Gary S.,Waksman Ron

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference31 articles.

1. Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-individual patient data pooled analysis from 6 randomized controlled trials;Konigstein;Am Heart J,2019

2. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials;Cutlip;Circulation,2004

3. In-stent restenosis in the drug-eluting stent era;Dangas;J Am Coll Cardiol,2010

4. TCT-117 the burden of restenosis after coronary stent implantation in the United States: temporal trends, clinical presentation, treatment strategies, and in-hospital outcomes;Moussa;J Am Coll Cardiol,2018

5. Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis;Maluenda;Circ Cardiovasc Interv,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis;International Journal of Cardiology;2024-11

2. We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons;EuroIntervention;2024-05

3. Peripheral Drug-Coated Balloon for Coronary Drug-Eluting Stent In-Stent Restenosis: Off-Label, Off-Target;Journal of the Society for Cardiovascular Angiography & Interventions;2024-02

4. Myths and Truths in the Management of Drug-Eluting Stent In-Stent Restenosis;JACC: Cardiovascular Interventions;2024-01

5. Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation;Folia Medica;2023-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3